Published in Br Med J on June 18, 1977
Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin). Proc Natl Acad Sci U S A (1966) 3.16
Appearance of T-cell markers in bone marrow rosette-forming cells after incubation with thymosin, a thymic hormone. Proc Natl Acad Sci U S A (1971) 3.13
Implantation of a foetal thymus, restoring immunological competence in a patient with thymic aplasia (Digeorge's syndrome). Lancet (1968) 2.40
Studies on thymus products. IV. Absence of serum 'thymic activity' in adult NZB and (NZB x NZW) F1 mice. Clin Exp Immunol (1973) 1.93
Influenza: response of T-cell lymphopenia to thymosin. N Engl J Med (1976) 1.69
Immunocompetence of spleen cells from neonatally thymectomized mice conferred in vitro by a syngeneic thymus extract. J Exp Med (1969) 1.47
Binding of autologous erythrocytes to immature T-cells. Proc Natl Acad Sci U S A (1975) 1.43
Acceleration by thymosin of the development of resistance to murine sarcoma virus-induced tumor in mice. Proc Natl Acad Sci U S A (1970) 1.38
Endocrine function of the thymus affecting neuromuscular transmission. Clin Exp Immunol (1969) 1.37
Biochemical characterisation of a serum thymic factor. Nature (1977) 1.33
Thymic factors. Prog Allergy (1976) 1.33
Thymosin restores T cell function and reduces the incidence of amyloid disease in casein-treated mice. J Immunol (1976) 1.31
Differentiation of human bone marrow cells into T lymphocytes by in vitro incubation with thymic extracts. Clin Exp Immunol (1974) 1.29
Studies on thymus products. 3. Epithelial origin of the serum thymic factor. Immunology (1974) 1.27
Enhancement of T-lymphocyte differentiation in vitro by thymic extracts after bone marrow transplantation in severe combined immunodeficiencies. Clin Immunol Immunopathol (1975) 1.04
Use of thymosin in the treatment of primary immunodeficiency diseases and cancer. Med Clin North Am (1976) 1.02
In vitro and in vivo studies with thymosin in cancer patients. Ann N Y Acad Sci (1976) 1.00
Correction of T cell function by thymosin in New Zealand mice. J Immunol (1974) 0.98
Increased reactivity of responding cells in the mixed lymphocyte reaction by a thymic humoral factor. Eur J Immunol (1975) 0.94
Restoration of delayed hypersensitivity to sheep erythrocytes by thymosin treatment of T-cell-depleted mice. Infect Immun (1976) 0.92
In vitro responses of rat lymphocytes following adult thymectomy. III. Prevention by thymic factor of increased suppressor activity in the spleen. Cell Immunol (1976) 0.88
Immunodeficiency in chronic uremia. Preliminary evidence for thymosin deficiency. Transplantation (1975) 0.87
Studies of thymic factors. I. Evaluation of the mouse rosette assay for thymic hormone. J Immunol (1975) 0.84
Thymosin-induced increase in E-rosette-forming capacity of lymphocytes in patients with malignant neoplasms. Cancer (1975) 0.82
Studies on thymus products. V. Influence of genetic selection based on antibody production on thymus hormone production. Clin Exp Immunol (1974) 0.80
Study of thymic factors. II. Failure of thymosin to alter the natural history of NZB and NZB/NZW mice. Arthritis Rheum (1976) 0.78
Thymic hormones as regulators of immune responses. Ann N Y Acad Sci (1976) 0.77
In vitro effect of thymosin on T cells from immunodepressed surgical patients. Surgery (1976) 0.77
Thymic hormone modulation of leukemogenic virus replication. Cancer Res (1976) 0.77